• New investment to fuel growth trajectory and development of award-winning, next-gen XiFin® Empower platform
• Funding led by a co-investment from Goldman Sachs, alongside majority investor Avista Healthcare Partners and other leading institutional investors

XiFin, a leader in revenue cycle management (RCM) and billing solutions enhanced with embedded artificial intelligence (AI), today announced a new growth capital investment, as well as the addition of health IT innovator and futurist Jeff Margolis to its Board of Directors. The funding round builds on XiFin’s 19% year-over-year growth, driven by client adoption of its flagship next-gen platform, XiFin® Empower, and successful execution of compelling business opportunities. The funding was led by a co-investment from Goldman Sachs External Investing Group, alongside investments from majority investor Avista Healthcare Partners and other leading institutional investors. Financial terms were not disclosed.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250903291755/en/

XiFin welcomes Jeffrey H. Margolis, visionary Health IT innovator and board member for multiple companies, to its Board of Directors.

“XiFin is uniquely positioned to capitalize on an inflection point in the industry, with AI presenting a once-in-a-generation opportunity to modernize RCM,” said Erik Sallee, Chief Financial Officer at XiFin. “With the support of our blue-chip investors, we have excellent financial flexibility to continue solving complex healthcare challenges and delivering industry-leading technology to more partners.”

The new growth investments follow strong demand for XiFin’s award-winning technology infrastructure that unifies automation, data analytics, and AI to streamline revenue cycle workflows, improve financial performance, and enhance the patient/provider experience. Built with real-time data exchange and interoperability at its core, XiFin Empower RCM connects patients, healthcare and pharmaceutical providers, and payors across the health ecosystem, extending medical providers’ reach for maximum operational and clinical impact.

“Our growth capital commitment underscores a strong conviction in XiFin and the critical role its industry-leading technology plays in modernizing healthcare RCM,” said Marc Boheim, Head of Co-Investments at Goldman Sachs External Investing Group. “We believe the company has an impressive trajectory of value creation, both organically and through acquisitions, as providers turn to trusted platforms like XiFin Empower RCM to help navigate the care delivery life cycle.”

Visionary Health IT Innovator Jeff Margolis Joins XiFin Board

XiFin’s Board will benefit from the addition of Jeff Margolis, a healthcare information technology veteran with extensive experience in AI innovation. He brings more than 35 years of expertise as an operating executive, having led as CEO multiple innovative healthcare technology companies, including founding TriZetto, the industry’s first vertical SaaS platform, with market-leading benefit plan administration solutions that serve over 130 million people. Margolis currently serves as a Senior Advisor to Blackstone, and board member for multiple companies, guiding strategic investments and advancing innovation in healthcare and IT. He is the author of several books evaluating the state of healthcare, including The Healthcare Cure and, most recently, Not Just in Sickness…but Also in Health.

“XiFin is supporting America’s healthcare providers—from hospitals and health systems, to pharmacies, ancillary and diagnostic services, to pharmaceutical companies—with solutions that unite a disconnected ecosystem, redefine RCM, and maintain focus on patient care,” Margolis said. “I am excited to work with XiFin’s management team and deep bench of industry experts to help providers capitalize on proprietary AI solutions that create tremendous efficiencies and benefit all stakeholders.”

About XiFin

XiFin is a healthcare information technology company that empowers organizations to navigate an evolving and increasingly complex healthcare landscape. Leveraging AI-enabled technologies and services, the XiFin Empower platform delivers enhanced operational efficiency, increased productivity and workflow automation. Our comprehensive set of solutions – spanning revenue cycle management, clinical workflow enablement, laboratory information systems, and patient engagement – provides healthcare organizations with the tools they need to achieve financial strength, optimize operations, and implement industry-leading strategies. XiFin Empower solutions deliver THE POWER TO DO GOOD® so that healthcare organizations can do more good for more patients. Visit www.XiFin.com, follow XiFin on LinkedIn, or subscribe to the XiFin blog to learn more.

About Avista Healthcare Partners

Founded in 2005, Avista Healthcare Partners is a leading New York-based private equity firm with over $10 billion invested in 50 growth-oriented healthcare businesses globally. Avista partners with businesses that feature strong management teams, stable cash flows and robust growth prospects – targeting healthcare product and technology businesses with clear scale potential across six sub-sectors experiencing strong tailwinds. The team is supported by a group of seasoned Strategic Executives enhancing the entire investment process through strategic insight, long-term value and sustainable businesses. For more information, visit www.avistahealthcare.com or follow Avista on LinkedIn.

About Goldman Sachs

Goldman Sachs (NYSE: GS) is one of the leading investors in alternatives globally, with over $500 billion in assets and more than 30 years of experience. The business invests in the full spectrum of alternatives, including private equity, growth equity, private credit, real estate, infrastructure, sustainability, and hedge funds. Clients access these solutions through direct strategies, customized partnerships, and open-architecture programs. Goldman Sachs is a leading global financial institution that delivers a broad range of financial services to a large and diversified client base that includes corporations, financial institutions, governments and individuals. Founded in 1869, the firm is headquartered in New York and maintains offices in all major financial centers around the world.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250903291755/en/

“XiFin is uniquely positioned to capitalize on an inflection point in the industry, with AI presenting a once-in-a-generation opportunity to modernize RCM,” said Erik Sallee, Chief Financial Officer at XiFin.